Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Assessment of BRAF and KIT mutations in Japanese melanoma patients.

Ashida A, Uhara H, Kiniwa Y, Oguchi M, Murata H, Goto Y, Uchiyama A, Ogawa E, Hayashi K, Koga H, Okuyama R.

J Dermatol Sci. 2012 Jun;66(3):240-2. doi: 10.1016/j.jdermsci.2012.03.005. Epub 2012 Apr 5. No abstract available.

PMID:
22534474
2.

BRAF, KIT and NRAS mutations and expression of c-KIT, phosphorylated extracellular signal-regulated kinase and phosphorylated AKT in Japanese melanoma patients.

Oyama S, Funasaka Y, Watanabe A, Takizawa T, Kawana S, Saeki H.

J Dermatol. 2015 May;42(5):477-84. doi: 10.1111/1346-8138.12822. Epub 2015 Mar 13.

PMID:
25766129
3.

NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing.

Edlundh-Rose E, Egyházi S, Omholt K, Månsson-Brahme E, Platz A, Hansson J, Lundeberg J.

Melanoma Res. 2006 Dec;16(6):471-8.

PMID:
17119447
4.

Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients.

Sakaizawa K, Ashida A, Uchiyama A, Ito T, Fujisawa Y, Ogata D, Matsushita S, Fujii K, Fukushima S, Shibayama Y, Hatta N, Takenouchi T, Uehara J, Okuyama R, Yamazaki N, Uhara H.

J Dermatol Sci. 2015 Oct;80(1):33-7. doi: 10.1016/j.jdermsci.2015.07.012. Epub 2015 Jul 26.

PMID:
26282084
5.

Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort.

Si L, Kong Y, Xu X, Flaherty KT, Sheng X, Cui C, Chi Z, Li S, Mao L, Guo J.

Eur J Cancer. 2012 Jan;48(1):94-100. doi: 10.1016/j.ejca.2011.06.056. Epub 2011 Jul 23.

PMID:
21788131
6.

KIT gene mutations and copy number in melanoma subtypes.

Beadling C, Jacobson-Dunlop E, Hodi FS, Le C, Warrick A, Patterson J, Town A, Harlow A, Cruz F 3rd, Azar S, Rubin BP, Muller S, West R, Heinrich MC, Corless CL.

Clin Cancer Res. 2008 Nov 1;14(21):6821-8. doi: 10.1158/1078-0432.CCR-08-0575.

7.

Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies.

Saldanha G, Potter L, Daforno P, Pringle JH.

Clin Cancer Res. 2006 Aug 1;12(15):4499-505.

8.

KIT, NRAS, and BRAF mutations in nail apparatus melanoma.

Dika E, Altimari A, Patrizi A, Gruppioni E, Fiorentino M, Piraccini BM, Misciali C, Barisani A, Fanti PA.

Pigment Cell Melanoma Res. 2013 Sep;26(5):758-60. doi: 10.1111/pcmr.12123. Epub 2013 Jun 20. No abstract available.

PMID:
23782496
9.

Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma.

Akslen LA, Puntervoll H, Bachmann IM, Straume O, Vuhahula E, Kumar R, Molven A.

Melanoma Res. 2008 Feb;18(1):29-35. doi: 10.1097/CMR.0b013e3282f32517.

PMID:
18227705
10.

KIT pathway alterations in mucosal melanomas of the vulva and other sites.

Omholt K, Grafström E, Kanter-Lewensohn L, Hansson J, Ragnarsson-Olding BK.

Clin Cancer Res. 2011 Jun 15;17(12):3933-42. doi: 10.1158/1078-0432.CCR-10-2917.

11.

Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.

Willmore-Payne C, Holden JA, Tripp S, Layfield LJ.

Hum Pathol. 2005 May;36(5):486-93.

PMID:
15948115
12.

KIT amplification and gene mutations in acral/mucosal melanoma in Korea.

Yun J, Lee J, Jang J, Lee EJ, Jang KT, Kim JH, Kim KM.

APMIS. 2011 Jun;119(6):330-5. doi: 10.1111/j.1600-0463.2011.02737.x. Epub 2011 Mar 24.

PMID:
21569090
13.

The molecular profile of metastatic melanoma in Australia.

Lyle M, Haydu LE, Menzies AM, Thompson JF, Saw RP, Spillane AJ, Kefford RF, Mann GJ, Cooper WA, Yu B, Scolyer RA, O'Toole SA, Long GV.

Pathology. 2016 Feb;48(2):188-93. doi: 10.1016/j.pathol.2015.12.008. Epub 2016 Jan 18.

PMID:
27020391
14.
15.

B-RAF and melanocytic neoplasia.

Gill M, Celebi JT.

J Am Acad Dermatol. 2005 Jul;53(1):108-14. Review.

PMID:
15965430
16.

Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal.

Miller DD, Emley A, Yang S, Richards JE, Lee JE, Deng A, Hoang MP, Mahalingam M.

Mod Pathol. 2012 Apr;25(4):505-15. doi: 10.1038/modpathol.2011.196. Epub 2011 Dec 9.

17.

Unexpected distribution of cKIT and BRAF mutations among southern Italian patients with sinonasal melanoma.

Colombino M, Lissia A, Franco R, Botti G, Ascierto PA, Manca A, Sini MC, Pisano M, Paliogiannis P, Tanda F, Palmieri G, Cossu A.

Dermatology. 2013;226(3):279-84. doi: 10.1159/000350683. Epub 2013 Jun 29.

PMID:
23817129
18.

MC1R germline variants confer risk for BRAF-mutant melanoma.

Landi MT, Bauer J, Pfeiffer RM, Elder DE, Hulley B, Minghetti P, Calista D, Kanetsky PA, Pinkel D, Bastian BC.

Science. 2006 Jul 28;313(5786):521-2. Epub 2006 Jun 29.

19.

BRAF mutations and KIT aberrations and their clinicopathological correlation in 202 Korean melanomas.

Jin SA, Chun SM, Choi YD, Kweon SS, Jung ST, Shim HJ, Yun SJ.

J Invest Dermatol. 2013 Feb;133(2):579-82. doi: 10.1038/jid.2012.338. Epub 2012 Sep 27. No abstract available.

20.

BRAF, NRAS and KIT sequencing analysis of spindle cell melanoma.

Kim J, Lazar AJ, Davies MA, Homsi J, Papadopoulos NE, Hwu WJ, Bedikian AY, Woodman SE, Patel SP, Hwu P, Kim KB.

J Cutan Pathol. 2012 Sep;39(9):821-5. doi: 10.1111/j.1600-0560.2012.01950.x. Epub 2012 Jul 19.

Supplemental Content

Support Center